Pulmonx Corp share price logo

Pulmonx Corp Share Price

NASDAQ: LUNG

Small Cap

$1.47

+0.01

(+0.34%)

as on

Pulmonx Corp Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.46
    $1.53
    downward going graph

    0.68%

    Downside

    4.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.13
    $5.46
    downward going graph

    23.13%

    Downside

    271.36%

    Upside

    downward going graph

Pulmonx Corp share price movements today

Previous Close
$1.46
Open
$1.50
Volume
315.1K
Day's Low - High
$1.46 - $1.53
52 Week Low - High
$1.13 - $5.46

Pulmonx Corp Historical Returns

1 Month Return
-0.68 %
3 Month Return
-16.95 %
1 Year Return
-67.48 %
3 Year Return
-87.67 %
5 Year Return
-96.65 %

Pulmonx Corp Stock Fundamentals & Key Indicators

Check Pulmonx Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$62.1M

EPS (TTM)

-1.1367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-52.6M

Revenue (TTM)

90.5M

Profit Margin

-59.67%

Return On Equity TTM

-77.19%

Pulmonx Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pulmonx Corp image
Pulmonx Corp
BUY$62.1M-96.65%NA-59.67%
Boston Scientific Corp image
Boston Scientific Corp
BUY$94.3B57%32.6914.44%
Stryker Corporation image
Stryker Corporation
BUY$129.6B33.52%40.3312.92%
Medtronic PLC image
Medtronic PLC
BUY$110.7B-31.55%23.9413.00%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$47.0B-9.02%44.7517.69%
See all

Stock Returns calculator for Pulmonx Corp Stock including INR - Dollar returns

The Pulmonx Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pulmonx Corp investment value today

Current value as on today

₹35,231

Returns

-₹64,769

(-64.77%)

Returns from Pulmonx Corp Stock

-₹67,478 (-67.48%)

Dollar Impact

₹2,709 (+2.71%)

Analyst Recommendation on Pulmonx Corp Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Pulmonx Corp. Average target price of $5.17

Pulmonx Corp Share Price Target

Get share price movements and forecasts by analysts on Pulmonx Corp.

What analysts predicted

71.57%UPSIDE

Target Price

$5.17

Current Price

$1.47

Analyzed by

11 Analysts

Target

$5.17

Pulmonx Corp target price $5.17, a slight upside of 71.57% compared to current price of $1.47. According to 11 analysts rating.

Pulmonx Corp Stock’s Investor Sentiment and Interest

Search interest for Pulmonx Corp Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-29% versus previous 30 day period

Pulmonx Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
17
19
18
20
20
23
22
23
21
22
Gross Profit
13
14
13
15
15
17
16
17
16
17
Operating Income
-15
-13
-14
-15
-14
-13
-14
-14
-14
-9
EBITDA
-13
-12
-12
-13
-12
-13
-14
-13
-12
-9
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-13
-13
-15
-13
-13
-14
-14
-13
-10
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-14
-13
-13
-15
-14
-13
-14
-15
-13
-10
Net Profit Margin
-84.33%
-72.04%
-72.92%
-73.74%
-69.38%
-55.44%
-64.11%
-63.59%
-64.91%
-46.13%

Pulmonx Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
20
32
32
48
53
68
83
90
Gross Profit
0
-
12
22
21
35
39
50
62
67
Operating Income
-2
-5
-15
-17
-32
-47
-58
-61
-57
-53
EBITDA
-
-
-15
-16
-28
-46
-55
-55
-50
-52
Interest Expense
-
-
2
2
3
0
1
3
3
3
Depreciation
-
-
0
0
0
0
1
1
1
1
Income Before Tax
-2
-5
-18
-20
-32
-48
-58
-60
-55
-53
Income Tax Expense
-
-
0
0
0
0
0
0
0
0
Net Income
-2
-5
-18
-20
-32
-48
-58
-60
-56
-54
Net Profit Margin
-31539.27%
0.00%
-92.38%
-63.52%
-98.47%
-100.51%
-109.80%
-88.60%
-67.30%
-59.67%

Pulmonx Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-13
-13
-15
-14
-13
-14
-15
-13
-10
Operating Cash Flow
-8
-11
-5
-7
-6
-13
-3
-8
-7
Investing Cash Flow
-2
-2
0
6
14
16
5
8
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
-11
-13
-6
0
7
3
0
1
-6

Pulmonx Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-18
-20
-32
-48
-58
-60
-56
-54
Operating Cash Flow
-4
-18
-20
-30
-41
-45
-37
-31
-32
Investing Cash Flow
0
0
-14
12
-46
-4
-2
17
30
Financing Cash Flow
5
12
45
234
4
2
21
1
0
Change in Cash
0
-5
10
217
-83
-46
-18
-12
-1

Global Institutional Holdings in Pulmonx Corp

Funds
Holdings
Geode Capital Management, LLC
2.15%
Dimensional Fund Advisors, Inc.
1.12%
BRAIDWELL LP
1.78%
Kent Lake PR LLC
2.19%
Geode Capital Management, LLC
2.37%
See all

Insights on Pulmonx Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -15.17M → -10.42M (in $), with an average increase of 21.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 21.50M → 22.59M (in $), with an average increase of 4.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 13.2% return, outperforming this stock by 80.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Pulmonx Corp has experienced a drawdown of -88.1%, however Boston Scientific Corp. resisted the overall trend and outperformed by 81.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, LUNG stock has moved down by -67.5%

About Pulmonx Corp

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
OrganisationPulmonx Corp
Headquarters700 Chesapeake Drive, Redwood City, CA, United States, 94063
IndustryMedical Devices
CEOMr. Glendon E. French
E-voting on sharesClick here to vote

Key Management of Pulmonx Corp

Name

Title

Mr. Geoffrey Beran Rose

Chief Commercial Officer

Dr. Derrick Sung Ph.D.

CFO & COO

Mr. Jérôme Erath

Senior VP & GM of International

Mr. Sri Radhakrishnan

Chief Science & Technology Officer

Ms. Marcee M. Maroney

Vice President of Marketing

Ms. Lisa Paul

Chief People Officer

Dr. Narinder S. Shargill Ph.D.

Senior Vice President of Global Medical & Clinical Affairs

Mr. John B. McKune

VP of Finance & Corporate Controller

Mr. Glendon E. French

CEO, President & Director

Mr. David A. Lehman J.D.

General Counsel & Secretary

FAQs

What is Pulmonx Corp share price today?

Pulmonx Corp share price today is $1.47 as on at the close of the market. Pulmonx Corp share today touched a day high of $1.53 and a low of $1.46.

What is the 52 week high and 52 week low for Pulmonx Corp share?

Pulmonx Corp share touched a 52 week high of $5.46 on and a 52 week low of $1.13 on . Pulmonx Corp stock price today i.e. is closed at $1.47,which is 73.07% down from its 52 week high and 30.09% up from its 52 week low.

What is Pulmonx Corp's market capitalisation today?

Pulmonx Corp market capitalisation is $0.00T as on .

How to invest in Pulmonx Corp Stock (LUNG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pulmonx Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Corp Shares that will get you 1.0204 shares as per Pulmonx Corp share price of $1.47 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pulmonx Corp Stock (LUNG) from India?

Indian investors can start investing in Pulmonx Corp (LUNG) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Pulmonx Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Pulmonx Corp share’s latest price of $1.47 as on April 18, 2026 at 1:29 am IST, you will get 6.8027 shares of Pulmonx Corp. Learn more about fractional shares .

What are the returns that Pulmonx Corp has given to Indian investors in the last 5 years?

Pulmonx Corp stock has given -96.65% share price returns and 24.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?